Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency

被引:269
作者
Tang, BW
Böttinger, EP
Jakowlew, SB
Bagnall, KM
Mariano, J
Anver, MR
Letterio, JJ
Wakefield, LM
机构
[1] NCI, Lab Cell Regulat & Carcinogenesis, Bethesda, MD 20892 USA
[2] Natl Canc Inst, Cell & Canc Biol Dept, Rockville, MD 20850 USA
[3] Sci Applicat Int Corp, Frederick Canc Res & Dev Ctr, Pathol Histotechnol Lab, Frederick, MD 21702 USA
关键词
D O I
10.1038/nm0798-802
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Components of the transforming growth factor-beta (TGF-beta) signal pathway function as classic tumor suppressors, but the role of the TGF-beta s themselves is less clear. Here we show that mice heterozygous for deletion of the TGF-beta 1 gene express only 10-30% of wild-type TGF-beta 1 protein levels. Although grossly normal, these mice have a subtly altered proliferative phenotype, with increased cell turnover in the liver and lung. Treatment of these mice with chemical carcinogens resulted in enhanced tumorigenesis when compared with wild-type littermates. However, tumors in the heterozygous mice did not lose the remaining wild-type TGF-beta 1 allele, indicating that the TCF-beta 1 ligand is a new form of tumor suppressor that shows true haploid insufficiency in its ability to protect against tumorigenesis.
引用
收藏
页码:802 / 807
页数:6
相关论文
共 46 条
  • [1] TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR
    BORDER, WA
    RUOSLAHTI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 1 - 7
  • [2] Böttinger EP, 1997, CANCER RES, V57, P5564
  • [3] Brattain Michael G., 1996, Current Opinion in Oncology, V8, P49, DOI 10.1097/00001622-199601000-00009
  • [4] Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure - The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
    Cambien, F
    Ricard, S
    Troesch, A
    Mallet, C
    Generenaz, L
    Evans, A
    Arveiler, D
    Luc, G
    Ruidavets, JB
    Poirier, O
    [J]. HYPERTENSION, 1996, 28 (05) : 881 - 887
  • [5] CARR BI, 1986, CANCER RES, V46, P2330
  • [6] GENOMIC SEQUENCING
    CHURCH, GM
    GILBERT, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07): : 1991 - 1995
  • [7] CROCKER TT, 1970, CANCER RES, V30, P357
  • [8] TGF beta 1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
    Cui, W
    Fowlis, DJ
    Bryson, S
    Duffie, E
    Ireland, H
    Balmain, A
    Akhurst, RJ
    [J]. CELL, 1996, 86 (04) : 531 - 542
  • [9] SPECIFIC AND SENSITIVE QUANTITATION OF TRANSFORMING GROWTH-FACTOR BETA-3 BY SANDWICH ENZYME-LINKED-IMMUNOSORBENT-ASSAY
    DANIELPOUR, D
    ROBERTS, AB
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 180 (02) : 265 - 272
  • [10] Sandwich Enzyme-Linked Immunosorbent Assays (SELISAs) Quantitate and Distinguish Two Forms of Transforming Growth Factor-Beta (TGF-beta 1 and TGF-beta 2) in Complex Biological Fluids
    Danielpour, David
    Kim, Kyung-Young
    Dart, Linda L.
    Watanabe, Shinichi
    Roberts, Anita B.
    Sporn, Michael B.
    [J]. GROWTH FACTORS, 1989, 2 (01) : 61 - 71